Adial Pharmaceuticals (ADIL) Q1 2025 Earnings
ADIL·Reported May 14, 2025·Before market open
Diluted EPS came in at $-0.34 (+50.0% YoY), beat the $-0.50 consensus by $0.16.
Diluted EPS
$-0.34beat by $0.16
Consensus: $-0.50
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Adial Pharmaceuticals's Q1 2025 earnings report.
Adial Pharmaceuticals (ADIL) reported Q1 2025 earnings on May 14, 2025 before market open.
Adial Pharmaceuticals reported diluted EPS of $-0.34 for Q1 2025.
EPS beat the consensus estimate of $-0.50 by $0.16.
Compared to the same quarter a year prior, diluted EPS grew 50.0% from $-0.68.
You can read the 10-Q periodic report (0001213900-25-043281) directly on SEC EDGAR. The filing index links above go to sec.gov.